logo-loader

Pan American Silver misses on 3Q earnings and revenue; says on track for production guidance

Last updated: 10:58 07 Nov 2018 EST, First published: 10:17 07 Nov 2018 EST

silver and gold bars
Pan American Silver is the world's second largest primary silver producer.

Pan American Silver Corp (TSX:PAA) (NASDAQ:PAAS) reported a miss on third-quarter earnings and revenue while reiterating it is on track to hit its 2018 production guidance.

The company said EPS came in at a loss of US$0.03, compared with a gain in the same period last year of US$0.15 and the consensus it would rise by US$0.05. Revenue reached US$187.7 million, compared with US$190.79 million a year ago and the consensus of US$198.95 million.

"The depressed metal prices had a significant impact on both settlement adjustments on concentrate shipments and NRV inventory adjustments, which together reduced earnings in the quarter by approximately $33.2 million," said company president and CEO Michael Steinmann.

Shares of Pan American Silver in New York were down 5% to US$14.31. In Canada, the shares were weaker by 4.93% to C$18.89. 

BIG PICTURE: Viscount Mining’s US gold and silver assets offer huge potential upside

Pan American Silver is maintaining the guidance provided on August 8, 2018, except for project capital. Estimated project capital in 2018 has been reduced to US$40 million from US$50 million due to timing of expenditures.

For silver, the company is guiding output on November 6 at 25 - 26.5 million ounces, unchanged from its guidance. The guidance for gold production remained steady at 175,000 to 185,000 ounces. 

The guidance for zinc and lead production was also flat at 60,000-62,000 tonnes and 21,000-22,000 tonnes, respectively.

The guidance for copper output was reduced to 9,000 to 10,400 tonnes, from the January forecast of 12,000 to 12,500 tonnes.

Pan American Silver is the world's second-largest primary silver producer. The company owns and operates six mines in Mexico, Peru, Argentina and Bolivia.

The company is based in Vancouver, Canada.

Reporting by Rene Pastor, contactable on rene.pastor@proactiveinvestors.com

Xeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for...

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...

14 hours, 37 minutes ago